Breast Surgery Complete Guide: Augmentation, Lift, and Reduction Explained
A comprehensive, evidence-based guide to breast augmentation, mastopexy, and reduction mammaplasty covering implant types, surgical techniques, risks, recovery timelines, and how to evaluate your options — with specific guidance for Istanbul medical tourism patients.
Last reviewed: 2026-05-06
46 min read
Ready to explore your options in Istanbul?
Connect with our coordination team for a personalised treatment plan, verified provider matching, and travel logistics support.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
Breast surgery encompasses several distinct procedures, each designed to address different concerns. Whether you are considering an increase in breast size, a lift for sagging tissue, or a reduction to relieve physical symptoms, understanding your options is the first step toward making an informed decision. This guide covers the three primary breast procedures — augmentation, mastopexy (breast lift), and reduction mammaplasty (breast reduction) — along with the evidence on implant types, surgical techniques, documented risks, and practical guidance for patients researching their options.
This resource is educational in nature and is not a substitute for a professional surgical consultation. Every patient's anatomy, health history, and goals are different. If you are considering any breast procedure, seek consultations with board-certified plastic surgeons who perform these procedures regularly, and discuss your specific situation in person.
Key takeaways
The three procedures address different primary concerns — augmentation adds volume, lift repositions, reduction removes tissue; many patients benefit from combined procedures but each carries its own risk profile
No breast implant lasts forever — plan for at least one revision in your lifetime; approximately 15-20% of augmentation patients seek revision within 10 years
BIA-ALCL is rare and nearly exclusively linked to recalled macro-textured implants; smooth implants carry near-zero risk; Allergan Biocell was recalled in 2019
Breast Implant Illness is a recognized patient experience; the FDA has received 10,318 MDRs; discuss any systemic symptoms with your surgeon
Choose a board-certified surgeon at an accredited (JCI) facility — verify credentials yourself; surgeon experience is the single most important variable in outcomes
Istanbul offers experienced surgeons at significant cost savings, but plan carefully for continuity of care after returning home, including a local physician for follow-up
Educational information only
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Understanding Your Options — The Three Breast Procedures
The three principal breast surgery categories are distinct in their primary goals, surgical approach, and the outcomes they can reasonably achieve. Understanding these differences is foundational before diving into the details of any specific procedure. For more on the full range of face and body procedures, explore our face and body resource hub.
What Is Breast Augmentation?
Breast augmentation — clinically termed augmentation mammoplasty — uses prosthetic implants to increase breast size, restore volume lost after weight reduction or pregnancy, or improve symmetry between breasts. It is the most commonly performed cosmetic surgical procedure in the United States, according to the American Society of Plastic Surgeons 2024 statistics (S7). Globally, hundreds of thousands of augmentation procedures are performed annually, with Turkey ranking among the top 10 countries globally for breast surgery (S21).
The primary method uses breast implants (saline or silicone gel), though fat transfer augmentation is an alternative for select patients. Fat transfer involves removing adipose tissue from another body area via liposuction and injecting it into the breasts — limited primarily by fat graft survival rates and donor fat availability. It is worth mentioning as an option but is not the primary focus of this guide.
For patients whose primary concern is that their breasts have begun to sag or droop, augmentation alone may not achieve the desired result. Placing an implant behind a droopy breast can result in a phenomenon surgeons call "Snoopy deformity" — the implant sits high on the chest wall while the nipple points downward. In such cases, a breast lift (mastopexy) or a combined approach may be recommended instead. See our dedicated breast augmentation resource page and breast augmentation treatment page for more detail.
What Is a Breast Lift (Mastopexy)?
Mastopexy is a surgical procedure that removes excess skin and reshapes breast tissue to elevate the nipple-areola complex and improve overall breast contour. A lift does not significantly change breast volume — it reshapes and repositions what is already there. The primary indication is breast ptosis, which is the medical term for sagging.
| Grade | Nipple Position | Relationship to Inframammary Fold | Breast Tissue Position |
|-------|----------------|-----------------------------------|------------------------|
| Grade I (minor) | At or just below fold | Above fold | Above fold |
| Grade II (moderate) | Below fold | Below fold but above most breast tissue | Above fold |
| Grade III (severe) | Lowest point of breast | Well below fold | At or below fold |
| Pseudoptosis | Below fold | Below fold | Below fold (empty sac) |
The degree of ptosis — along with skin quality, tissue volume, and the patient's goals — determines which surgical technique is most appropriate. Mastopexy can be performed with or without implants. Patients seeking both lift and volume increase may benefit from a combined procedure, though this carries a higher risk profile than either procedure alone (discussed below).
Common causes of breast ptosis include gravity, pregnancy and breastfeeding, significant weight fluctuations, loss of skin elasticity with age, smoking, and prior surgeries.
Reduction mammaplasty removes breast tissue, fat, and skin to achieve a breast size proportional to the patient's body. It is distinct from mastopexy in that significant tissue volume is removed, not just reshaped. The procedure is medically indicated when oversized breasts cause physical symptoms such as chronic neck, shoulder, or back pain; bra strap grooving; intertrigo (skin rash beneath the breasts); postural problems; or activity limitations. Patient satisfaction rates for reduction consistently exceed 90% across multiple studies, according to StatPearls (S4).
In many countries, breast reduction may be covered by health insurance when symptoms are medically documented and the tissue to be removed meets certain thresholds. These thresholds vary significantly by insurer and policy — common ranges are 400-600 grams per breast, though some insurers use different criteria. Patients should verify their specific policy before assuming coverage.
For patients who are candidates for reduction, the procedure can be transformative from both a functional and psychosocial perspective. Physical activity levels often increase post-operatively, and pain symptoms improve in approximately 80-95% of patients (S4). For more detail, see our breast reduction resource page and breast reduction treatment page.
Combined Augmentation-Mastopexy: When You Need Both
Many patients present wanting both more volume and correction of sagging. This combination — simultaneous augmentation and mastopexy — is among the most challenging procedures in breast surgery. The nipple must effectively move in two different directions at once: it must be elevated (mastopexy) while the breast mound beneath it is expanded by an implant (augmentation). This creates competing vectors and tension on the tissue.
According to research analyzing 73,608 patients from the MAARS database (S8), the complication rate for augmentation-mastopexy combined is approximately 1.86%, compared to 1.15% for mastopexy alone. The literature consistently identifies this combination as higher-risk than either procedure performed in isolation.
Two surgical approaches exist:
One-stage (combined): Single surgery, one recovery period, potentially lower total cost. Best suited to patients with moderate ptosis, mild volume deficiency, and excellent tissue quality. Not all surgeons offer this approach.
Two-stage: Tissue expander placed first, then implant exchange in a second surgery; or mastopexy performed first followed by implant placement 3-6 months later. This approach generally carries a lower complication rate and is often recommended for patients with more severe ptosis. It involves two recoveries and two anesthetics.
Patient selection is paramount. Surgeon experience is the single most important variable in outcomes for combined procedures. If you are considering this combination, ask your surgeon directly about their experience with simultaneous augmentation-mastopexy and their complication and revision rates for this specific procedure.
Breast Implants — Types, Shapes, and Specifications
Choosing an implant is one of the most consequential decisions in breast augmentation. The type, shape, surface texture, size, profile, and placement all affect the aesthetic outcome, the complication profile, and the long-term maintenance requirements. No implant is right for every patient, and no implant is lifetime guaranteed.
Feature
Feature
Saline
Silicone Gel
Structured (IDEAL)
FDA approval age
18+
22+
18+
Feel
Firmer; more prone to rippling
Most natural feel
Improved vs. traditional saline
Rupture detection
Obvious — deflates and body absorbs saline
Often silent — MRI needed
Obvious — deflates
MRI required
No
Yes — at 5-6 years, then every 2-3 years
No
Incision size
Smaller (fillable during surgery)
Larger (pre-filled at manufacturer)
Smaller (adjustable)
Rippling risk
Higher
Lower
Lower than traditional saline
Deflation obvious?
Yes — absorbed safely by body
No — siliconoma may form
Yes
Key consideration
Safe, adjustable, less natural feel
Natural feel; MRI monitoring required
Combines safety and aesthetics; less long-term data
Silicone gel implants are FDA-approved for women 22 and older (S1). They contain a cohesive gel that maintains shape while mimicking the feel of natural breast tissue more closely than saline. The gel is designed to hold together if the implant shell tears, though this does not make rupture undetectable.
One of the most important considerations with silicone implants is that rupture is often "silent" — meaning the patient may not notice any change in breast shape or feel. For this reason, the FDA recommends MRI screening at 5-6 years post-implantation and every 2-3 years thereafter (S1, S5). Detecting silent rupture early matters because an undetected intracapsular rupture — where silicone pools within the scar capsule — can lead to granuloma formation (siliconoma) and may require surgical removal.
Silicone implants require a larger incision than saline implants because they are pre-filled at the manufacturer. This is a practical consideration when discussing incision options with your surgeon.
Saline Implants
Saline implants are FDA-approved for women 18 and older (S1, S14). They consist of a silicone shell filled with sterile saline solution at the time of surgery, which allows the surgeon to adjust the fill volume intraoperatively. If the shell ruptures, the saline is safely absorbed by the body and the deflation is immediately obvious — the breast loses its volume within days or weeks.
Saline implants may feel less natural, particularly in patients with thin breast tissue or limited existing volume. They are also more prone to visible rippling (the edges of the implant becoming palpable or visible through the skin). However, their obvious deflation mechanism provides a built-in early warning system that silicone implants lack, and no MRI monitoring is required.
Structured (IDEAL) Implants
The IDEAL IMPLANT received FDA 510(k) clearance in 2014 (S19). It is a structured implant — meaning it has internal baffles or nested shells that give it more internal stability than a traditional saline implant. Manufacturers market this as combining the safety of saline (obvious deflation if rupture occurs) with improved aesthetics and reduced rippling compared to traditional saline implants.
The important caveat is that the IDEAL implant has less long-term data than traditional saline or silicone types. Patients choosing this option should discuss this trade-off explicitly with their surgeon and understand the follow-up requirements.
Round vs. Teardrop Shapes
Round implants provide equal projection in all directions and tend to deliver fuller upper-pole fullness. Because they are symmetrical, rotation does not cause visible deformity. Most primary augmentations use round implants.
Teardrop (anatomical or contoured) implants are shaped to mimic the natural slope of the breast — fuller at the bottom, gradually tapering toward the top. They are designed to provide a more natural contour, particularly in patients with limited existing tissue. However, teardrop implants require a textured surface to stay in position, because rotation of a teardrop implant causes visible deformity. This means choosing a teardrop implant necessarily involves the texture risk discussion (see below).
The choice between round and teardrop depends on your anatomy, goals, and willingness to accept the texture risk trade-off. Discuss this with your surgeon.
Textured vs. Smooth Surface
Textured implants were designed to reduce capsular contracture — the scar tissue tightening around the implant that can cause pain and distortion. Some studies showed lower contracture rates with textured surfaces, particularly in the subglandular (above-muscle) placement plane.
However, the risk calculus changed significantly when BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma, discussed in detail below) entered the medical literature. BIA-ALCL is almost exclusively linked to macro-textured implants — specifically the Allergan Biocell product line, which was the highest-texture product on the market. Allergan recalled all Biocell macro-textured implants and tissue expanders in 2019 (S10) following an FDA-requested voluntary recall.
Smooth implants carry near-zero risk of BIA-ALCL. They are the most commonly used type in the United States market today. They do carry a somewhat higher risk of capsular contracture in some placement positions compared to textured implants, but the contracture risk can be managed through placement technique, implant massage (where appropriate), and regular monitoring.
BIA-ALCL and Implant Texture
BIA-ALCL is almost exclusively linked to macro-textured (textured) implants. Smooth implants carry near-zero risk. Allergan Biocell — the highest-risk product — was recalled in 2019. Any late-onset swelling or seroma after the first year should be evaluated by a plastic surgeon. BIA-ALCL is a lymphoma of the immune system — it is NOT breast cancer. When detected early and treated with implant removal and complete capsulectomy, it can often be cured.
The inframammary fold (IMF) incision is the most common approach in current practice. The scar is hidden in the natural crease beneath the breast and provides direct access to the surgical pocket. It is compatible with all implant types and provides the most precise control over implant placement.
The periareolar approach involves an incision around the edge of the areola. The scar can be less visible, but this approach may affect nipple sensation (the nerves that control sensation travel through this area) and limits the size of implant that can be inserted because the incision is bounded by the areola diameter.
The transaxillary approach places the incision in the armpit, avoiding any scar on the breast itself. However, it is compatible only with saline implants or very small silicone implants, and provides less precise control over the implant pocket. Endoscopic assistance can improve precision.
The TUBA (transumbilical breast augmentation) approach places the implant through an incision at the belly button, using a tunnel to reach the breast. This is rarely recommended and is only suitable for saline implants. Most surgeons do not offer this approach because of the limited precision.
Placement: Above or Below the Muscle
Implant placement refers to the position of the implant relative to the pectoralis major muscle:
Subglandular (above the muscle) placement positions the implant between the breast tissue and the chest muscle. This approach typically involves a shorter, less painful recovery and can produce a more natural movement pattern during activity. However, it carries a higher risk of capsular contracture and may result in more visible palpability and rippling, particularly in thin patients.
Subpectoral (partial or full coverage below the muscle) provides the muscle as an additional tissue layer over the implant. This lowers the capsular contracture risk in some studies and can improve mammography imaging. The disadvantages include a longer, potentially more uncomfortable early recovery (the muscle is stretched during implant placement) and "animation deformity" — where the implant moves unnaturally when the chest muscle contracts during physical activity.
Athletic patients, especially those who regularly use the chest muscle, should discuss animation deformity risk with their surgeon before choosing subpectoral placement. Some experienced surgeons have techniques to minimize this effect.
Fat Transfer: An Alternative Approach
Fat transfer augmentation — also called fat grafting or autologous fat transfer — removes adipose tissue via liposuction from areas such as the abdomen, flanks, or thighs and processes it for injection into the breasts. It avoids the use of prosthetic implants entirely and can simultaneously contour the donor area.
However, fat transfer for breast augmentation has important limitations:
Survival rates vary: Not all transferred fat survives; some is reabsorbed by the body. Studies suggest 50-70% retention rates, meaning revision procedures may be needed.
Limited volume increase: The degree of volume increase per session is more limited than what an implant can achieve in a single procedure.
Requires adequate donor fat: Lean patients may not have sufficient donor tissue.
Cannot effectively correct significant ptosis: Fat transfer adds volume but does not lift drooping tissue.
Fat transfer is more commonly used in breast reconstruction after mastectomy and for revision procedures where implant rippling or edges need to be camouflaged. Patients interested in fat transfer should discuss realistic expectations with their surgeon.
Understanding Risks and Complications
All surgical procedures carry documented risks. No surgery is risk-free. Understanding the specific complication rates, risk factors, and warning signs for each procedure type helps you make a more informed decision and recognize when you need to seek medical attention.
Capsular Contracture
After any implant is placed, the body naturally forms a thin layer of scar tissue around it — this is called the capsule and is a normal healing response. In some patients, this capsule tightens and squeezes the implant. This tightening is called capsular contracture.
| Grade | Description | Patient Experience |
|-------|-------------|---------------------|
| Baker I | Soft; no contracture | Natural feel; implant moves freely |
| Baker II | Mild; slight firmness | No pain; normal appearance |
| Baker III | Moderate; firm; mild distortion | May feel tight; some visible cosmetic change |
| Baker IV | Severe; hard; painful; marked distortion | Pain; significant cosmetic change; implant displaced |
The incidence of capsular contracture varies from approximately 10-30% (S9) depending on implant type, placement plane, surgical technique, and patient factors. Subglandular (above-muscle) placement carries a higher contracture risk than subpectoral placement (S3, S14). Textured implants historically showed lower contracture rates in some studies, but the texture-BIA-ALCL trade-off has changed practice patterns.
Treatment options include implant exchange with capsulectomy (surgical removal of the scar capsule), medications (such as leukotriene receptor antagonists — evidence is limited and these are not FDA-approved for this use), and in some cases implant removal alone may be sufficient.
Breast Implant Rupture
Implant rupture can be intracapsular (the shell is torn but the scar capsule remains intact and contains the silicone gel) or extracapsular (the tear extends beyond the capsule and gel escapes into the surrounding breast tissue) (S5).
Saline implant rupture is typically obvious — the saline is absorbed by the body and the breast deflates visibly within days or weeks.
Silicone gel implant rupture is frequently "silent" — the cohesive gel maintains its shape even when the shell is torn, and the patient may not notice any change. This is why the FDA recommends MRI screening for silicone implant patients.
MRI is the gold standard for detecting silicone implant rupture (S5), showing a characteristic "linguine sign" — the collapsed implant shell appearing as a thin, wavy line within the scar capsule. Ultrasound is useful for initial assessment of palpable concerns or seroma evaluation but is less sensitive than MRI for detecting intracapsular rupture. Mammography is not reliable for rupture detection, though additional displacement views (Eklund views) can improve cancer screening in implant patients.
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
BIA-ALCL is a rare T-cell lymphoma that develops in the scar fluid (seroma) surrounding a breast implant or within the scar capsule itself. It is NOT breast cancer — it is a lymphoma of the immune system. BIA-ALCL is a serious diagnosis, but when detected early and treated according to NCCN Guidelines, it can often be cured.
Epidemiology (S6):
Lifetime risk approximately 1:2,207 to 1:86,029 in women with textured implants, varying by texture type
733 confirmed cases reported to the FDA as of August 2020
1,380 medical device reports (MDRs) received by FDA as of February 2025
64 deaths reported globally in confirmed BIA-ALCL cases
73% of confirmed cases had textured implants
Allergan Biocell accounts for approximately 86% of cases where the manufacturer is known
The 2019 Allergan Biocell recall (S10) removed the highest-risk macro-textured implant from the market following an FDA-requested voluntary recall. Smooth implants and micro-textured implants carry significantly lower BIA-ALCL risk.
Diagnosis (S6, S11):
CD30 immunohistochemistry (IHC) testing of seroma fluid or tissue is the diagnostic test
Any late-onset (>1 year post-operatively), unilateral seroma should prompt BIA-ALCL evaluation
Ultrasound is first-line imaging; MRI may assess for mass or capsule involvement
BIA-ALCL is NOT diagnosed by mammogram, standard cancer screening, or routine follow-up
NCCN Guidelines (2024) provide the diagnostic and treatment algorithm
Treatment (S6, S11):
NCCN Guidelines recommend complete implant removal AND complete capsulectomy (total surgical removal of the scar capsule) for localized disease
For advanced disease: chemotherapy, brentuximab vedotin in some cases, and radiation therapy in select cases
Complete removal is often curative for localized disease
Implant replacement is generally not recommended until disease evaluation is complete; if replacement is desired after cure, smooth implants are recommended
BIA-ALCL — What Patients Should Know
BIA-ALCL is almost exclusively linked to macro-textured (textured) implants. Smooth implants carry near-zero risk. Allergan Biocell — the highest-risk product — was recalled in 2019. Any late-onset swelling or seroma after the first year should be evaluated by a plastic surgeon. BIA-ALCL is a lymphoma of the immune system — it is NOT breast cancer. When detected early and treated with implant removal and complete capsulectomy, it can often be cured.
Breast Implant Illness (BII)
Breast Implant Illness is a patient-coined but FDA-recognized term for a constellation of systemic symptoms that some patients attribute to their breast implants. The FDA acknowledges these as real symptoms reported by patients; however, no consensus causal mechanism has been established and no definitive diagnostic test exists (S2, S12, S13).
10,318 medical device reports received between 2008-2024
Average time from implant to symptom onset: 5.6 years
Average time from symptom onset to implant removal: 9.1 years
Both silicone and saline implants are reported in these MDRs
Important caveat: MDR (Medical Device Report) data represents reports submitted to the FDA, not confirmed cases or incidence rates in the broader implant population. These numbers reflect reported events and should not be interpreted as prevalence rates.
BII is a diagnosis of exclusion — other causes of symptoms must be ruled out before attributing them to implants. Management options include explanation (implant removal with or without capsulectomy), implant exchange to a different type, and comprehensive pre-explant medical workup including autoimmune and endocrine evaluation.
Breast Implant Illness — What Patients Should Know
Breast Implant Illness is a real patient experience recognized by the FDA. If you have systemic symptoms you believe are related to your implants — such as fatigue, joint pain, brain fog, or other unexplained symptoms — discuss your concerns with a board-certified surgeon. Removal (explantation) with or without capsulectomy is the primary management approach. Some patients report symptom improvement or resolution after removal, though recovery timelines vary and the evidence on causal mechanism remains evolving. Symptoms may have other causes — thorough medical evaluation is important before attributing them to implants.
General Surgical Risks
Beyond procedure-specific complications, all breast surgeries carry general risks including:
Anesthesia risk: Reactions to anesthesia vary by patient health status; discuss your anesthesia provider's qualifications with your surgeon
Bleeding and hematoma: Accumulation of blood under the skin may require surgical drainage in the operating room
Infection: Occurs in fewer than 1% of cases but is a serious complication requiring antibiotics and possibly implant removal
Seroma: Fluid accumulation under the skin; may require drainage
Changes in nipple and areola sensation: Affects approximately 10-15% of patients; usually temporary but can be permanent
Scarring: Varies by technique, patient healing, and scar maturity; scars continue to mature for 12-18 months
Delayed wound healing: More common in smokers, diabetics, and patients with elevated BMI
DVT/PE (deep vein thrombosis/pulmonary embolism): Risk from post-operative immobility; early ambulation and possibly anticoagulation measures reduce this risk
Unsatisfactory aesthetic result: May require revision surgery
Smoking and Wound Healing
Smoking significantly increases the risk of wound healing complications across all breast procedures — including nipple necrosis, wound separation, poor scarring, and capsular contracture. Most surgeons require smoking cessation at least 4-6 weeks before and after surgery. This is not optional — it is one of the most significant modifiable risk factors for your surgical outcome.
Very limited application; rarely performed standalone
Circumareolar (Donut)
Grade I-II
Around areola only
Mild ptosis with periareolar skin excess
Risk of widening scar; limited lifting capacity
Vertical lollipop
Grade II (moderate)
Around areola + vertical to fold
Moderate ptosis; most common technique
Learning curve for surgeons; may bottom out over time
Wise pattern (anchor)
Grade II-III (moderate-severe)
Around areola + vertical + horizontal fold
Severe ptosis; major reshaping; large reductions
Highest scar burden; T-junction healing risk
More severe ptosis generally requires more extensive techniques with higher scar burden but more reliable and lasting correction.
Reduction Mammaplasty Surgical Techniques
Reduction technique varies primarily in how the nipple-areola complex (NAC) is preserved and how tissue is removed and reshaped. The inferior pedicle technique is the most commonly used approach (S4), though other approaches are used in select cases:
Feature
Technique
NAC Preservation
Scar Pattern
Best for
Limitations
Inferior pedicle (anchor)
Preserved on inferior pedicle with blood supply from below
Around areola + vertical + horizontal fold
Large reductions; most widely used technique
Highest scar burden; T-junction healing risk
Superior/superomedial pedicle
Preserved on superior or superomedial pedicle
Around areola + vertical; no horizontal fold in some designs
Moderate-large reductions; better upper pole shape
More technically demanding; limited to certain ptosis grades
Vertical (lollipop) reduction
Preserved on superior pedicle
Around areola + vertical only
Moderate reductions; limited skin excision
May not be adequate for very large reductions; bottoming-out risk
Free nipple graft
Removed completely and reapplied as full-thickness graft
No pedicle; skin graft required
Extremely large breasts; high-risk patients (e.g., smokers)
Loss of sensation; no breastfeeding; aesthetic limitations
Liposuction-assisted
No NAC repositioning; volume reduction only
Minimal stab incisions only
Small-to-moderate reductions; good skin retraction candidates
Cannot address significant ptosis; limited to fatty tissue composition
For extremely large breasts or high-risk patients, the free nipple graft technique eliminates pedicle length concerns but results in permanent loss of nipple sensation and inability to breastfeed. Liposuction-assisted reduction offers the least scarring but cannot address significant ptosis or remove skin.
Reduction Complications
Breast reduction has historically higher overall complication rates (50-53.9%) compared to augmentation or mastopexy alone, driven by longer surgical time and larger surface area of dissection. BMI greater than 30 significantly increases wound healing complications. Smokers face substantially elevated risk of nipple necrosis and wound separation.
Which Procedure Is Right for You?
Choosing the right procedure depends primarily on your primary concern — what you most want to change about your breasts — along with your anatomy, health factors, lifestyle, and expectations. This section provides a framework to help you understand your options, but it cannot substitute for an in-person examination by an experienced surgeon.
Decision Framework — What Is Your Primary Concern?
"I want larger breasts / more volume"
If your primary concern is that your breasts are too small or have lost volume after weight loss or pregnancy, breast augmentation is your principal procedure option. An implant adds volume. If moderate ptosis is present, combining augmentation with a lift may be recommended to avoid Snoopy deformity (where the implant sits high and the nipple points down). Key decisions include implant type, size, profile, and placement.
"My breasts are droopy / my nipples point downward"
If your primary concern is sagging or drooping — regardless of size — a breast lift (mastopexy) is the appropriate procedure. A lift reshapes and repositions existing tissue without adding significant volume. Augmentation alone in a ptotic breast will not correct drooping and may worsen the appearance. Patients who want both lift and volume should discuss combined augmentation-mastopexy with an experienced surgeon.
"My breasts are too large and cause physical symptoms"
If oversized breasts cause chronic pain, bra strap grooving, intertrigo, or limit physical activity, breast reduction removes tissue and reshapes proportionally. This procedure may be covered by insurance when symptoms are medically documented. Satisfaction rates exceed 90% and functional symptom improvement is documented in 80-95% of patients.
"I want both larger and higher breasts"
Combined augmentation-mastopexy addresses both simultaneously but is the most complex breast surgery combination. The literature consistently identifies it as higher-risk than either procedure alone. Not all surgeons offer a one-stage approach. A two-stage approach may be recommended for patients with severe ptosis. Surgeon experience is paramount.
Key Factors in Your Decision
Beyond your primary concern, several additional factors should influence your procedure choice and surgical planning:
Tissue quality and skin elasticity: Poor skin elasticity increases recurrence risk after mastopexy (sagging can return more quickly). Thin tissue increases risk of visible implant rippling.
Body proportions and frame: Chest wall width determines safe implant base width. Shoulder and hip proportions influence ideal breast width.
Lifestyle factors: Athletic patients who regularly use the chest muscle may experience animation deformity with subpectoral placement. Smokers face significantly elevated wound healing risk and must quit 4-6 weeks before and after surgery.
Reproductive and breastfeeding plans: Pregnancy and breastfeeding after surgery can alter results. Breastfeeding capacity may be affected by reduction (discuss pedicle technique with your surgeon). Augmentation does not prevent breastfeeding but may affect sensation important to the let-down reflex.
Willingness to accept revision: Lifetime revision rates are real. No guarantees exist. Patients should plan financially and emotionally for at least one potential revision surgery.
Psychological readiness: Unrealistic expectations must be addressed before surgery. Body dysmorphic disorder (BDD) screening may be appropriate. Mental health clearance may be recommended in some cases.
The Importance of an In-Person Examination
This guide cannot determine which procedure is right for any individual patient. The surgeon must physically examine your tissue thickness and quality, skin elasticity (pinch test), degree of ptosis, nipple-to-fold distance, chest wall symmetry, and areola size and position. A single consultation is rarely sufficient to make a final decision. Getting 2-3 opinions from board-certified surgeons who perform these procedures regularly is a reasonable and common approach.
What to Look for in a Surgeon and Facility
Surgeon experience is the single most important modifiable factor in breast surgery outcomes. This is true across all three procedure types, and it is especially critical for combined augmentation-mastopexy.
TPRECD verification — The Turkish Society of Plastic Reconstructive and Aesthetic Surgeons is the professional body for plastic surgeons in Turkey
Turkish Board of Plastic Surgery (TBPS) certification — Confirm board certification independently
JCI facility accreditation — Verify the specific hospital campus, not just the parent organization
In the United States:
ABMS/ABPS certification — The American Board of Plastic Surgery (S20) is the only board recognized by the American Board of Medical Specialties for plastic surgery. "Board certified cosmetic surgeon" is not equivalent — it may indicate certification by a non-ABMS board. Verify at abplsurg.org.
State medical license — Confirm the license is current and unrestricted
Hospital privileges — Even for outpatient procedures, hospital privileges indicate the surgeon has undergone peer review
Malpractice history — Public records can be searched in most states
Verify Credentials Independently
Verify your surgeon's credentials yourself. Do not rely solely on clinic websites or patient coordinators. Check ISAPS membership, TPRECD verification, and facility JCI accreditation directly through the issuing organizations before committing. In the US, confirm ABMS/ABPS board certification at the official website. Guarantees of outcomes, promises of "risk-free" surgery, and prices significantly below market rate are red flags.
Key questions to ask a prospective surgeon:
How many of this specific procedure do you perform per year?
What is your complication rate, and how do you handle complications?
Can I speak with a patient who had this procedure (where permitted by privacy law)?
What brand of implants do you use, and why?
Where will the procedure be performed?
What is your revision rate for this procedure?
What happens if I need emergency care after I am discharged?
What is your follow-up schedule?
If I am an international patient, what does your aftercare and communication plan look like once I return home?
Facility Standards — JCI and Beyond
JCI (Joint Commission International) accreditation is the primary global standard for medical tourism facilities. Accreditation indicates the facility has undergone regular inspection against international safety and quality standards, including:
Surgeon and anesthesiologist credentialing
Emergency preparedness protocols
Infection control standards
Equipment maintenance and monitoring
Quality monitoring and improvement processes
Verify the specific hospital campus or surgical center, not just the parent organization. A clinic within a larger hospital system may not itself hold JCI accreditation.
Confirm anesthesiologist qualifications: is a board-certified anesthesiologist present for the full case? What post-operative monitoring is provided? How long will you be in the facility?
Allergan (AbbVie) — saline and silicone (Biocell recall 2019 — only smooth and micro-textured types remain on the US market)
Sientra — silicone gel
IDEAL Implant — structured saline (S19)
International clinics may use these manufacturers' products or other FDA-equivalent-approved devices. Patients should confirm the implant brand, model, and approval status before the procedure to avoid any bait-and-switch concern.
The Istanbul Medical Tourism Context
Turkey is among the top 5 countries globally for medical tourism (S21) and ranks in the top 10 globally for breast surgery procedures. Istanbul in particular has developed a significant medical tourism sector serving patients from Europe, the Middle East, and the Gulf states. Understanding the specific considerations for Istanbul-based care helps you plan more effectively.
Why Istanbul Is a Major Destination for Breast Surgery
Global context (S7, S21):
Turkey is a top 5 global medical tourism destination; top 10 globally for breast surgery
Significant cost advantages: 40-70% lower than US/UK for comparable surgeons at accredited facilities
Many Istanbul surgeons have international training and certifications
All-inclusive pricing packages are common, simplifying planning for international patients
Short flight times from Europe, Middle East, and Gulf states
Istanbul-specific advantages:
High surgical volume means experienced practitioners
JCI-accredited hospital systems are available (verify specific campus)
Medical tourism infrastructure: recovery hotels with nursing support, airport transfers, patient coordinators
English widely spoken in medical tourism facilities
Pre-Travel Planning for Breast Surgery
Medical preparation before arriving in Istanbul:
Bring all prior mammogram and breast ultrasound reports and images on CD
Compile a complete medical history including medications, allergies, and prior surgeries
Stop smoking at least 4-6 weeks before surgery — this is required by most surgeons and is not optional (S3, S4)
Optimize your weight — most surgeons prefer BMI below 35; some may accept up to 38 with risk stratification (S4)
Review all current medications with your surgeon; blood thinners and certain supplements may need to be stopped
Establish a local primary care physician in your home country who can manage follow-up imaging and any post-operative concerns after you return
Logistics:
Arrange airport pickup, accommodation, and local transportation before arrival
Confirm you will have a companion for the first 24-48 hours post-operatively
Plan for a minimum 5-7 days in Istanbul after your procedure before any air travel
Verify your travel insurance covers complications that may arise from the procedure
Understand the cancellation and revision policies before committing financially
Post-operative air travel risk:
Air travel after breast surgery increases DVT/PE risk due to cabin pressure and post-operative immobility. Most surgeons require a minimum 7-14 days before commercial flight. Longer flights carry higher risk. Compression stockings and prophylactic anticoagulation may be recommended for flights longer than 4-6 hours. Consider travel insurance with medical evacuation coverage.
Emergency Planning and Escalation
The single most important planning step for international patients is establishing continuity of care after returning home. This means having a local physician — not just your Istanbul surgeon — who can manage your follow-up, interpret imaging, and handle any urgent issues that arise.
Know before you are discharged:
The address and phone number of the nearest hospital with a 24-hour emergency department (not just a clinic)
Your surgeon's direct emergency contact number
The name and contact of your designated local follow-up physician
Recovery Timeline
Recovery varies by procedure type, surgical technique, extent of surgery, and individual healing. The following are general ranges based on clinical literature — your surgeon's specific instructions take precedence.
Immediate Post-Op (Days 1-7)
Augmentation:
Outpatient or 1-night observation
Compression surgical bra; no underwire for 6-8 weeks
Drains typically removed within 24-48 hours if used
Pain is moderate; controlled with oral analgesics; subpectoral patients typically report more early discomfort
Light activity from day 1; no lifting more than 5 lbs; no raising arms above shoulder level for 2 weeks
Return to desk work: 1-2 weeks
Return to physical labor: 4-6 weeks
Mastopexy:
Outpatient or 1-night observation
Surgical bra; no underwire 6-8 weeks
Drains if used
Pain is moderate; primarily from tissue rearrangement
Visible swelling and bruising peaks around days 3-5 then improves
Sensation changes may begin immediately or develop over the first several days
Reduction mammaplasty:
Often requires a 1-night hospital stay due to longer surgery duration and tissue disruption
Drains typically left 24-72 hours
Larger tissue removal generally means more post-operative discomfort
Return to desk work: 3-4 weeks; return to physical labor: 6 weeks
Weeks 2-6
Most swelling subsides progressively; the final shape is not yet visible at this stage
Scars begin to mature; silicone-based scar therapy may begin once wounds are fully closed and your surgeon approves
Gradually resume normal activity; no impact exercise until cleared at your follow-up appointment
Follow-up appointment typically at 2-3 weeks
Gradual transition from surgical bra to a support bra
Nipple sensation changes may be at their maximum — usually improve over the subsequent months
Months 3-12
The final aesthetic result becomes apparent between 6-12 months post-operatively
Scars continue to mature; the best scar appearance is typically achieved at 12-18 months
For silicone implant patients: schedule your MRI at 5-6 years per FDA recommendation (S1, S5)
Annual follow-up with your surgeon is recommended for all implant patients
Maintain a stable weight to help preserve your surgical results
Cost and Value
Understanding cost ranges and what drives pricing helps you evaluate options and avoid unexpected surprises.
Pricing Factors
Breast surgery costs are influenced by:
Procedure type (augmentation vs. lift vs. reduction vs. combined procedures)
Implant choice (silicone vs. saline vs. structured; brand)
Surgeon's experience, reputation, and geographic market
Facility type (JCI hospital vs. clinic vs. outpatient surgery center)
Anesthesia type and duration
Included services (post-operative garments, medications, follow-up visits, patient coordinator support)
General Cost Ranges (indicative, USD — verify current pricing)
United States:
Breast augmentation: $8,000-$15,000+ (surgeon, facility, anesthesia, implants)
Breast lift: $6,000-$12,000+
Breast reduction: $8,000-$15,000+ (insurance may cover when medically indicated)
Combined procedures: $12,000-$25,000+
United Kingdom:
Breast augmentation: £5,000-£10,000+
Breast lift: £6,000-£12,000+
Breast reduction: £7,000-£12,000+ (NHS covers many cases with documented medical indication)
Turkey (Istanbul):
Breast augmentation: $3,000-$6,000 (all-inclusive packages common)
Breast lift: $3,500-$7,000
Breast reduction: $3,500-$7,000
Combined procedures: $5,000-$9,000
All-inclusive packages in Istanbul typically include the surgeon fee, implants, facility fee, anesthesia, medications, post-operative garments, hotel accommodation, airport transfers, and patient coordinator. Patients should carefully review what is included and excluded before comparing to quotes from other markets.
Lower Cost Does Not Automatically Mean Lower Quality
A price significantly below market rate is not automatically a good deal — and it is not automatically evidence of comparable quality. A complication requiring revision surgery can quickly offset any initial savings. Regardless of where you have your procedure, verify surgeon credentials, facility accreditation, and implant brands independently. The cost of a revision surgery, combined with the physical and emotional toll, can be substantial.
Your Next Steps
Breast surgery is a significant decision that affects your body, health, and life. Taking the time to research thoroughly before committing helps you make a more informed choice and sets realistic expectations.
Here is what to do next:
Review this guide and note your specific questions. What is your primary concern? What have you tried so far? What are your biggest questions about the procedures, risks, and recovery?
Seek 2-3 consultations with board-certified plastic surgeons who perform these procedures regularly. A single consultation is rarely sufficient. Different surgeons may have different recommendations based on their experience and clinical judgment.
Verify credentials independently. Check surgeon certification through official registries, verify facility JCI accreditation, and review malpractice history before committing.
Bring a companion to your consultation who can help you process information and recall details after the visit.
Plan for continuity of care after any procedure — especially if you are considering surgery abroad. Identify a local physician who can manage follow-up before you commit.
If you are considering Istanbul, review the Istanbul-specific planning section carefully. Plan for a minimum 5-7 day stay post-operatively, arrange a companion for the first 24-48 hours, and establish your local follow-up physician before you travel.
If you are ready to take the next step in planning your breast surgery, our coordination team can help connect you with qualified, board-certified surgeons at JCI-accredited facilities in Istanbul. We will help you understand your options, coordinate your consultation, and support your planning logistics.
